Detailed Explanation
Cyclization is one of the most powerful tools in peptide drug design. Ring formation constrains the peptide into a defined conformation (reducing the entropic penalty of binding), shields backbone amide bonds from proteases, and can dramatically improve membrane permeability. Nature uses cyclic peptides extensively: cyclosporin A (immunosuppressant, 11 residues), oxytocin (disulfide-cyclized nonapeptide), and vancomycin (antibiotic) are all cyclic. Cyclization strategies include head-to-tail (backbone), side-chain-to-side-chain (disulfide, lactam, or thioether), and stapling (hydrocarbon cross-links). The recent renaissance in cyclic peptide drug discovery is driven by their ability to target 'undruggable' protein–protein interactions that small molecules can't reach and antibodies can't access intracellularly.
Key Facts
- Cyclization is one of the most powerful tools in peptide drug design
- Ring formation constrains the peptide into a defined conformation (reducing the entropic penalty of binding), shields backbone amide bonds from proteases, and can dramatically improve membrane permeability
- Nature uses cyclic peptides extensively: cyclosporin A (immunosuppressant, 11 residues), oxytocin (disulfide-cyclized nonapeptide), and vancomycin (antibiotic) are all cyclic
- Cyclization strategies include head-to-tail (backbone), side-chain-to-side-chain (disulfide, lactam, or thioether), and stapling (hydrocarbon cross-links)
- The recent renaissance in cyclic peptide drug discovery is driven by their ability to target 'undruggable' protein–protein interactions that small molecules can't reach and antibodies can't access intracellularly
Part of the PeptideBond.com education network